Table 2 Summary of HPV4 vaccine efficacy studies in men [56–58]
From: Towards the eradication of HPV infection through universal specific vaccination
Giuliano | Palefsky | Goldstone | |
|---|---|---|---|
Population | Per-protocol | Per-protocol | Per-protocol* |
(16-26 years) | (16-26 years) | (16-26 years) | |
External genital lesions | 90.4% | ||
(95% CI: 69.2-98.1) | |||
Anal intraepithelial neoplasia | 77.5% | 91.7% | |
(95% CI: 39.6-93.3) | (95% CI: 44.6-99.8) | ||
Condylomata acuminata | 89.4% | ||
(95% CI: 65.5-97.9) |